Novel Plasmodium vivax dhfr alleles from the Indonesian archipelago and Papua New Guinea: Association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 2, 2005, Pages 733-740

  Hastings, Michele D ^a   Maguire, Jason D ^b   Bangs, Michael J ^b,e   Zimmerman, Peter A ^c,d   Reeder, John C ^d   Baird, J Kevin ^b   Sibley, Carol Hopkins ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c US Naval Medical Research Unit No 2 Jakarta   (Indonesia)

^d PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^e Navy Disease Vector Ecology and Control Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FANSIDAR; FOLIC ACID ANTAGONIST;

ALLELE; ANTIBIOTIC RESISTANCE; ANTIMALARIAL ACTIVITY; CONTROLLED STUDY; DRUG SENSITIVITY; GENE DELETION; GENE EXPRESSION SYSTEM; GENE FREQUENCY; GENE INSERTION; GENE LOCUS; GENETIC VARIABILITY; HUMAN; INDONESIA; MAJOR CLINICAL STUDY; MALARIA; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PAPUA NEW GUINEA; PLASMODIUM VIVAX; POINT MUTATION; PRIORITY JOURNAL; PROTOZOAL GENETICS; REVIEW; SACCHAROMYCES CEREVISIAE; YEAST;

ALLELES; ANIMALS; ANTIMALARIALS; CLONING, MOLECULAR; CODON; DRUG RESISTANCE; FOLIC ACID ANTAGONISTS; INDONESIA; MICROBIAL SENSITIVITY TESTS; PAPUA NEW GUINEA; PLASMODIUM VIVAX; PYRIMETHAMINE; SACCHAROMYCES CEREVISIAE; TETRAHYDROFOLATE DEHYDROGENASE;

EID: 12944316449     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.2.733-740.2005     Document Type: Review

References (68)

1. Baird, J. K., M. F. Sustriayu Nalim, H. Basri, S. Masbar, B. Leksana, E. Tjitra, R. M. Dewi, M. Khairani, and F. S. Wignall. 1996. Survey of resistance to chloroquine by Plasmodium vivax in Indonesia. Trans. R. Soc. Trop. Med. Hyg. 90:409-411.
2. Barcus, M. J., Krisin, I. R. Elyazar, H. Marwoto, T. L. Richie, H. Basri, I. Wiady, D. J. Fryauff, J. D. Maguire, M. J. Bangs, and J. K. Baird. 2003. Primary infection by Plasmodium falciparum or P. vivax in a cohort of Javanese migrants to Indonesian Papua. Ann. Trop. Med. Parasitol. 97:565-574.
3. Barcus, M. J., F. Laihad, M. Sururi, P. Sismadi, H. Marwoto, M. J. Bangs, and J. K. Baird. 2002. Epidemic malaria in the Menoreh Hills of Central Java. Am. J. Trop. Med. Hyg. 66:287-292.
4. Bloland, P., S. Kachur, and H. Williams. 2003. Trends in antimalarial drug deployment in sub-Saharan Africa. J. Exp. Biol. 206:3761-3769.
5. Brega, S., F. de Monbrison, C. Severini, R. Udomsangpetch, I. Sutanto, P. Ruckert, F. Peyron, and S. Picot. 2004. Real-time PCR for dihydrofolate reductase gene single-nucleotide polymorphisms in Plasmodium vivax isolates. Antimicrob. Agents Chemother. 48:2581-2587.
6. Cortese, J. F., A. Caraballo, C. E. Contreras, and C. V. Plowe. 2002. Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. J. Infect. Dis. 186:999-1006.
7. Cortese, J. F., and C. V. Plowe. 1998. Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast. Mol. Biochem. Parasitol. 94:205-214.
8. Cowman, A. F. 1997. The mechanisms of drug action and resistance in malaria. Mol. Gen. Drug Resist. 3:221-246.
9. Cui, L., C. N. Mascorro, Q. Fan, K. A. Rzomp, B. Khuntirat, G. Zhou, H. Chen, G. Yan, and J. Sattabongkot. 2003. Genetic diversity and multiple infections of Plasmodium vivax malaria in Western Thailand. Am. J. Trop. Med. Hyg. 68:613-619.
10. de Pecoulas, P. E., B. Abdallah, M. K. Dje, L. K. Basco, J. leBras, and A. Mazzabraud. 1995. Use of a semi-nested PCR diagnosis test to evaluate antifolate resistance of Plasmodium falciparum isolates. Mol. Cell. Probes 9:391-397.
11. de Pecoulas, P. E., L. K. Basco, R. Tahar, T. Ouatas, and A. Mazabraud. 1998. Analysis of the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene sequence. Gene 211:177-185.
12. de Pecoulas, P. E., R. Tahar, T. Ouatas, A. Mazabraud, and L. K. Basco. 1998. Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance. Mol. Biochem. Parasitol. 92:265-273.
13. Doberstyn, E. B., C. Teerakiartkamjorn, R. G. Andre, P. Phintuyothin, and S. Noeypatimanondh. 1979. Treatment of vivax malaria with sulfadoxine- pyrimethamine and with pyrimethamine alone. Trans. R. Soc. Trop. Med. Hyg. 73:15-17.
14. Doi, H., A. Kaneko, W. Panjaitan, and A. Ishii. 1989. Chemotherapeutic malaria control operation by single dose of Fansidar plus primaquine in North Sumatra, Indonesia. Southeast Asian J. Trop. Med. Public Health 20:341-349.
15. Duraisingh, M. T., J. Curtis, and D. C. Warhurst. 1998. Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. Exp. Parasitol. 89:1-8.
16. Feng, X., J. M. Carlton, D. A. Joy, J. Mu, T. Furuya, B. B. Suh, Y. Wang, J. W. Barnwell, and X. Z. Su. 2003. Single-nucleotide polymorphisms and genome diversity in Plasmodium vivax. Proc. Natl. Acad. Sci. USA 100:8502-8507.
17. Ferlan, J. T., S. Mookherjee, I. N. Okezie, L. Fulgence, and C. H. Sibley. 2001. Mutagenesis of dihydrofolate reductase from Plasmodium falciparum: analysis in Saccharomyces cerevisiae of triple mutant alleles resistant to pyrimethamine or WR99210. Mol. Biochem. Parasitol. 113:139-150.
18. Foote, S. J., D. Galatis, and A. F. Cowman. 1990. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc. Natl. Acad. Sci. USA 87:3014-3017.
19. Fryauff, D. J., I. Sumawinata, Purnomo, T. L. Richie, E. Tjitra, M. J. Bangs, A. Kadir, and G. Ingkokusumo. 1999. In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest lrian Jaya, Indonesia. Am. J. Trop. Med. Hyg. 60:542-546.
20. Fryauff, D. J., S. Tuti, A. Mardi, S. Masbar, R. Patipelohi, B. Leksana, K. C. Kain, M. J. Bangs, T. L. Richie, and J. K. Baird. 1998. Chloroquine-resistant Plasmodium vivax in transmigration settlements of West Kalimantan, Indonesia. Am. J. Trop. Med. Hyg. 59:513-518.
21. Garg, M., N. Gopinathan, P. Bodhe, and N. A. Kshirsagar. 1995. Vivax malaria resistant to chloroquine: case reports from Bombay. Trans. R. Soc. Trop. Med. Hyg. 89:656-657.
22. Hankins, E. G., D. C. Warhurst, and C. H. Sibley. 2001. Novel alleles of the Plasmodium falciparum dhfr highly resistant to pyrimethamine and chlorcycloguanil, but not WR99210. Mol. Biochem. Parasitol. 117:91-102.
23. Hastings, M. D., K. M. Porter, J. D. Maguire, I. Susanti, W. Kania, M. J. Bangs, C. H. Sibley, and J. K. Baird. 2004. Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine. J. Infect. Dis. 189:744-750.
24. Hastings, M. D., and C. H. Sibley. 2002. Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax. Proc. Natl. Acad. Sci. USA 99:13137-13141.
25. Hyde, J. E. 2002. Mechanisms of resistance of Plasmodium falciparum to antimalarial drugs. Microbes Infect. 4:165-174.
26. Imwong, M., S. Pukrittakayamee, S. Looareesuwan, G. Pasvol, J. Poirreiz, N. J. White, and G. Snounou. 2001. Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates. Antimicrob. Agents Chemother. 45:3122-3127.
27. Imwong, M., S. Pukrittayakamee, L. Renia, F. Letourneur, J. P. Charlieu, U. Leartsakulpanich, S. Looareesuwan, N. J. White, and G. Snounou. 2003. Novel point mutations in the dihydrofolate reductase gene of Plasmodium vivax: evidence for sequential selection by drug pressure. Antimicrob. Agents Chemother. 47:1514-1521.
28. Ito, H., Y. Fukuda, K. Murata, and A. Kimura. 1983. Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 153:163-168.
29. Joy, D. A., X. Feng, J. Mu, T. Furuya, K. Chotivanich, A. U. Krettli, M. Ho, A. Wang, N. J. White, E. Suh, P. Beerli, and X. Z. Su. 2003. Early origin and recent expansion of Plasmodium falciparum. Science 300:318-321.
30. Korsinczky, M., K. Fischer, N. Chen, J. Baker, K. Rieckmann, and Q. Cheng. 2004. Sulfadoxine resistance in Plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxine-binding site. Antimicrob. Agents Chemother. 48:2214-2222.
31. Krisin, H. Basri, D. J. Fryauff, M. J. Barcus, M. J. Bangs, e. Ayomi, H. Marwoto, I. R. F. Elyazar, T. L. Richie, and J. K. Baird. 2003. Malaria in a cohort of Javanese migrants in Indonesian Papua. Ann. Trop. Med. Parasitol. 97:543-556.
32. Maguire, J. D., M. D. Lacy, Sururi, P. Sismadi, Krisin, I. Wiady, B. Laksana, M. J. Bangs, S. Masbar, I. Susanti, W. Basuki, M. J. Barcus, H. Marwoto, M. D. Edstein, S. Tjokrosonto, and J. K. Baird. 2002. Chloroquine or sulfadoxine-pyrimethamine for the treatment of uncomplicated, Plasmodium falciparum malaria during an epidemic in Central Java, Indonesia. Ann. Trop. Med. Parasitol. 96:655-668.
33. Maguire, J. D., I. W. Sumawinata, S. Masbar, B. Laksana, P. Prodjodipuro, I. Susanti, P. Sismadi, N. Mahmud, M. J. Bangs, and J. K. Baird. 2002. Chloroquine-resistant Plasmodium malariae in south Sumatra, Indonesia. Lancet 360:58-60.
34. Marlar-Than, Myat-Phone-Kyaw, Aye-Yu-Soe, Khaing-Khaing-Gyi, MaSabai, and Myint-Oo. 1995. Development of resistance to chloroquine by Plasmodium vivax in Myanmar. Trans. R. Soc. Trop. Med. Hyg. 89:307-308.
35. Mayxay, M., S. Pukritrayakamee, K. Chotivanich, M. Imwong, S. Looareesuwan, and N. J. White. 2001. Identification of cryptic coinfection with Plasmodium falciparum in patients presenting with vivax malaria. Am. J. Trop. Med. Hyg. 65:588-592.
36. Mayxay, M., S. Pukrittayakamee, P. N. Newton, and N. J. White. 2004. Mixed-species malaria infections in humans. Trends Parasitol. 20:233-240.
37. Mehlotra, R. K., L. J. Kasehagen, M. Baisor, K. Lorry, J. W. Kazura, M. J. Bockarie, and P. A. Zimmerman. 2002. Malaria infections are randomly distributed in diverse holoendemic areas of Papua New Guinea. Am. J. Trop. Med. Hyg. 67:555-562.
38. Mehlotra, R. K., K. Lorry, W. Kastens, S. M. Miller, M. P. Alpers, M. Bockarie, J. W. Kazura, and P. A. Zimmerman. 2000. Random distribution of mixed species malaria infections in Papua New Guinea. Am. J. Trop. Med. Hyg. 62:225-231.
39. Mendis, K., B. J. Sina, P. Marchesini, and R. Carter. 2001. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 64:97-106.
40. Meuwissen, T. 1964. The use of a medicated salt in an antimalaria campaign in West New Guinea. Trop. Geogr. Med. 16:245-255.
41. Mueller, I., J. Kaiok, J. C. Reeder, and A. Cortes. 2002. The population structure of Plasmodium falciparum and Plasmodium vivax during an epidemic of malaria in the Eastern Highlands of Papua New Guinea. Am. J. Trop. Med. Hyg. 67:459-464.
42. Nair, S., J. T. Williams, A. Brockman, L. Paiphun, M. Mayxay, P. N. Newton, J. P. Guthmann, F. M. Smithuis, T. T. Hien, N. J. White, F. Nosten, and T. J. Anderson. 2003. A selective sweep driven by pyrimethamine treatment in Southeast Asian malaria parasites. Mol. Biol. Evol. 20:1526-1536.
43. Peterson, D. S., W. K. Milhous, and T. E. Wellems. 1990. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falcipanim malaria. Proc. Natl. Acad. Sci. USA 87:3018-3022.
44. Peterson, D. S., D. Walliker, and T. E. Wellems. 1988. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc. Natl. Acad. Sci. USA 85:9114-9118.
45. Phillips, E. J., J. S. Keystone, and K. C. Kain. 1996. Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America. Clin. Infect. Dis. 23:1171-1173.
46. Plowe, C. V. 2003. Monitoring antimalarial drug resistance: making the most of the tools at hand. J. Exp. Biol. 206:3745-3752.
47. Plowe, C. V., A. Djimde, M. Bouare, O. Doumbo, and T. E. Wellems. 1995. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am. J. Trop. Med. Hyg. 52:565-568.
48. Plowe, C. V., J. G. Kublin, and O. K. Doumbo. 1998. P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates. Drug Resist. Updat. 1:389-396.
49. Pukrittayakamee, S., M. Imwong, S. Looareesuwan, and N. J. White. 2004. Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria. Acta Trop. 89:351-356.
50. Rastelli, G., S. Pacchioni, and M. D. Parenti. 2003. Structure of Plasmodium vivax dihydrofolate reductase determined by homology modeling and molecular dynamics refinement. Bioorg. Med. Chem. Lett. 13:3257-3260.
51. Roper, C., R. Pearce, B. Bredenkamp, J. Gumede, C. Drakeley, F. Mosha, D. Chandramohan, and B. Sharp. 2003. Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet 361:1174-1181.
52. Ruebush, T. K., II, J. Zegarra, J. Cairo, E. M. Andersen, M. Green, D. R. Pillai, W. Marquino, M. Huilca, E. Arevalo, C. Garcia, L. Solary, and K. C. Kain. 2003. Chloroquine-resistant Plasmodium vivax malaria in Peru. Am. J. Trop. Med. Hyg. 69:548-552.
53. Sibley, C. H., J. E. Hyde, P. F. Sims, C. V. Plowe, J. G. Kublin, E. K. Mberu, A. F. Cowman, P. A. Winstanley, W. M. Watkins, and A. M. Nzila. 2001. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol. 17:582-588.
54. Sikorski, R. S., and P. Hieter. 1989. A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122:19-27.
55. Singh, R. K. 2000. Emergence of Chloroquine-resistant vivax malaria in south Bihar (India). Trans. R. Soc. Trop. Med. Hyg. 94:327.
56. Siripoon, N., G. Snounou, P. Yamogkul, K. Na-Bangchang, and S. Thaithong. 2002. Cryptic Plasmodium falciparum parasites in clinical P. vivax blood samples from Thailand. Trans. R. Soc. Trop. Med. Hyg. 96:70-71.
57. Snounou, G., and N. J. White. 2004. The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand. Trends Parasitol. 20:333-339.
58. Soto, J., J. Toledo, P. Gutierrez, M. Luzz, N. Llinas, N. Cedeno, M. Dunne, and J. Berman. 2001. Plasmodium vivax clinically resistant to chloroquine in Colombia. Am. J. Trop. Med. Hyg. 65:90-93.
59. Sumawinata, I. W., Bernadeta, B. Leksana, A. Sutamihardja, Purnomo, B. Subianto, Sekartuti, D. J. Fryauff, and J. K. Baird. 2003. Very high risk of therapeutic failure with chloroquine for uncomplicated Plasmodium falciparum and P. vivax malaria in Indonesian Papua. Am. J. Trop. Med. Hyg. 68:416-420.
60. Tjitra, E., J. Baker, S. Suprianto, Q. Cheng, and N. M. Anstey. 2002. Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations. Antimicrob. Agents Chemother. 46:3947-3953.
61. Trape, J. F. 2001. The public health impact of chloroquine resistance in Africa. Am. J. Trop. Med. Hyg. 64:12-17.
62. Wallace, A. R. 1860. On the zoological geography of the Malay Archipelago (communicated by Charles Darwin to the LSL meeting of 3 November 1859). J. Proc. Linn. Soc. Zool. 4:172-184.
63. Wellems, T. E., and C. V. Plowe. 2001. Chloroquine-resistant malaria. J. Infect. Dis. 184:770-776.
64. Wilairatana, P., U. Silachamroon, S. Krudsood, P. Singhasivanon, S. Treeprasertsuk, V. Bussaratid, W. Phumratanaprapin, S. Srivilirit, and S. Looareesuwan. 1999. Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax malaria in Thailand. Am. J. Trop. Med. Hyg. 61:973-977.
65. Wongsrichanalai, C., A. L. Pickard, W. H. Wernsdorfer, and S. R. Meshnick. 2002. Epidemiology of drug-resistant malaria. Lancet Infect. Dis. 2:209-218.
66. Wooden, J. M., L. H. Hartwell, B. Vasquez, and C. H. Sibley. 1997. Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum. Mol. Biochem. Parasitol. 85:25-40.
67. Wootton, J. C., X. Feng, M. T. Ferdig, R. A. Cooper, J. Mu, D. I. Baruch, A. J. Magill, and X. Z. Su. 2002. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 418:320-323.
68. Young, M. D., and R. W. Burgess. 1959. Pyrimethamine resistance in Plasmodium vivax malaria. Bull. W. H. O. 20:27-36.